Anticancer Effects of Sinocrassulosides VI/VII from Silene viscidula on HeLa Cells.

Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer (2009) 11.25

The regulation of INK4/ARF in cancer and aging. Cell (2006) 8.75

Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature (2011) 8.45

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol (1995) 6.26

Plants as a source of anti-cancer agents. J Ethnopharmacol (2005) 5.05

The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta (1998) 4.45

Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840. J Clin Oncol (2008) 4.09

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial. Lancet Oncol (2013) 3.70

Cellular senescence and tumor suppressor gene p16. Int J Cancer (2011) 2.14

A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas. Clin Cancer Res (2012) 1.21

p16INK4a as a second effector of the telomere damage pathway. Cell Cycle (2005) 1.18

Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence. Cancer Lett (2014) 1.01

Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner. PLoS One (2013) 0.95

Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-κB/mTOR signaling. Anticancer Res (2011) 0.93

Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells. J Invest Dermatol (2008) 0.91

Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects. J BUON (2011) 0.90

Advances in the research and development of natural health products as main stream cancer therapeutics. Evid Based Complement Alternat Med (2015) 0.84

Facile synthesis of triterpenoid saponins bearing β-Glu/Gal-(1→3)-β-GluA methyl ester and their cytotoxic activities. Bioorg Med Chem Lett (2012) 0.81

Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives. Phytochem Rev (2014) 0.81

MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma. Oncotarget (2016) 0.80

Phaseoloideside E, a novel natural triterpenoid saponin identified from Entada phaseoloides, induces apoptosis in Ec-109 esophageal cancer cells through reactive oxygen species generation. J Pharmacol Sci (2013) 0.80

Structure-activity relationships of saponins enhancing the cytotoxicity of ribosome-inactivating proteins type I (RIP-I). Toxicon (2013) 0.79

The apoptotic effect of D Rhamnose β-hederin, a novel oleanane-type triterpenoid saponin on breast cancer cells. PLoS One (2014) 0.78

A triterpenoid saponin from Adenophora triphylla var. japonica suppresses the growth of human gastric cancer cells via regulation of apoptosis and autophagy. Tumour Biol (2014) 0.77

Evaluation of novel saponins from Psammosilene tunicoides and their analogs as immunomodulators. Int Immunopharmacol (2012) 0.77

New triterpenoid saponins from the roots of Sinocrassula asclepiadea. Chem Pharm Bull (Tokyo) (2004) 0.77

A new triterpenoid saponin from the roots of Silene viscidula. Nat Prod Res (2011) 0.77

Chikusetsusaponin IVa methyl ester induces cell cycle arrest by the inhibition of nuclear translocation of β-catenin in HCT116 cells. Biochem Biophys Res Commun (2015) 0.77